We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+17.67%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.3B
AUM Growth
+$1.6B
Cap. Flow
+$186M
Cap. Flow %
1.65%
Top 10 Hldgs %
53.18%
Holding
660
New
44
Increased
183
Reduced
381
Closed
52

Top Buys

Rank Stock Value
1
MMP
Magellan Midstream Partners, L.P.
MMP
+$132M
2
TEP
Tallgrass Energy Partners, LP
TEP
+$104M
3
NGL icon
NGL Energy Partners
NGL
+$82.1M
4
SHLX
Shell Midstream Partners, L.P.
SHLX
+$43.3M
5
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
+$39.3M

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$88.3M
2
BN icon
Brookfield
BN
+$48.6M
3
DHR icon
Danaher
DHR
+$38.3M
4
PAA icon
Plains All American Pipeline
PAA
+$37.9M
5
BPL
Buckeye Partners, L.P.
BPL
+$32.7M

Sector Composition

Rank Sector Weight
1 Energy 69.1%
2 Materials 2.16%
3 Healthcare 1.94%
4 Financials 1.94%
5 Technology 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPXL
151
DELISTED
Impax Laboratories, Inc.
IPXL
$2.99M 0.03%
103,693
+22,043
+27% +$718K
PLD icon
152
Prologis
PLD
$138B
$2.92M 0.03%
59,605
-1,928
-3% -$90.6K
EQR icon
153
Equity Residential
EQR
$25.4B
$2.87M 0.03%
41,618
-1,163
-3% -$80K
GAU
154
Galiano Gold
GAU
$488M
$2.81M 0.02%
+738,208
New +$2.44M
VTR icon
155
Ventas
VTR
$48.4B
$2.78M 0.02%
38,160
-910
-2% -$59.9K
RARE icon
156
Ultragenyx Pharmaceutical
RARE
$2.65B
$2.68M 0.02%
54,816
+11,142
+26% +$721K
ISEE
157
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.54M 0.02%
49,689
+10,373
+26% +$515K
EXEL icon
158
Exelixis
EXEL
$14B
$2.51M 0.02%
+321,335
New +$1.85M
IRWD icon
159
Ironwood Pharmaceuticals
IRWD
$624M
$2.36M 0.02%
215,494
+44,350
+26% +$433K
TXMD icon
160
TherapeuticsMD
TXMD
$24.2M
$2.34M 0.02%
+5,514
New +$2.27M
BXP icon
161
Boston Properties
BXP
$11B
$2.3M 0.02%
17,467
-551
-3% -$70.7K
BLUE
162
DELISTED
bluebird bio
BLUE
$2.25M 0.02%
4,007
+801
+25% +$454K
AGIO icon
163
Agios Pharmaceuticals
AGIO
$2.16B
$2.23M 0.02%
53,272
+10,941
+26% +$540K
RDUS
164
DELISTED
Radius Health, Inc.
RDUS
$2.22M 0.02%
60,460
+12,086
+25% +$427K
DBVT
165
DBV Technologies
DBVT
$810M
$2.21M 0.02%
6,772
+1,350
+25% +$437K
FPRX
166
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.15M 0.02%
51,994
+38,705
+291% +$1.68M
VNO icon
167
Vornado Realty Trust
VNO
$7.55B
$2.01M 0.02%
24,871
-861
-3% -$66.7K
GGP
168
DELISTED
GGP Inc.
GGP
$1.98M 0.02%
66,376
-1,935
-3% -$54.6K
O icon
169
Realty Income
O
$60.8B
$1.97M 0.02%
29,304
-897
-3% -$54.4K
ONCE
170
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.97M 0.02%
38,489
+8,041
+26% +$344K
EBS icon
171
Emergent Biosolutions
EBS
$377M
$1.92M 0.02%
68,308
+11,000
+19% +$431K
DOC icon
172
Healthpeak Properties
DOC
$15.3B
$1.88M 0.02%
58,252
-1,619
-3% -$50.3K
PTLA
173
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.87M 0.02%
79,328
+16,013
+25% +$395K
SEMG
174
DELISTED
SEMGROUP CORPORATION
SEMG
$1.84M 0.02%
+56,493
New +$1.64M
DLR icon
175
Digital Realty Trust
DLR
$75.8B
$1.82M 0.02%
16,665
-582
-3% -$55.3K
5 6
7
8 9

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, ALPS Advisors held 660 positions worth $11.3B, up 17% from $9.68B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

ALPS Advisors's Q2 2016 filing shows 44 new, 183 increased, 381 reduced and 52 closed positions. Its largest new stake was NGL Energy Partners: 5,895,930 shares worth $114M. The largest sale was Energy Transfer Partners L.p., an estimated $88.3M.

By sector, the portfolio is most concentrated in Energy at 69% of assets, up from 67% a quarter earlier, followed by Materials and Healthcare.

  • ALPS Advisors's largest Q2 2016 buy was NGL Energy Partners: 5,895,930 shares worth $114M.
  • ALPS Advisors added most to Magellan Midstream Partners, L.P. in Q2 2016, an estimated $132M increase.
  • ALPS Advisors's biggest Q2 2016 reduction was Energy Transfer Partners L.p., cutting an estimated $88.3M.
  • ALPS Advisors fully exited Brookfield in Q2 2016, selling an estimated $48.6M.
  • ALPS Advisors's ten largest holdings make up 53% of its $11.3B portfolio in Q2 2016.
  • ALPS Advisors opened 44 new positions and closed 52 in Q2 2016.
  • ALPS Advisors's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on ALPS Advisors's 13F filing for Q2 2016, filed 27 Jul 2016.